Tyco Healthcare to separate from parent co., get new name

Tyco Healthcare announced that it will now be known as Covidien once the division separates from parent company Tyco International this spring and becomes an independent, publicly-traded company.
 
Tyco Healthcare is a global manufacturer and distributor of medical products, with annual sales of nearly $10 billion. Its product portfolio includes disposable medical supplies, monitoring equipment, medical instruments and bulk analgesic pharmaceuticals.
 
The Covidien brand will be the umbrella identity for brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture, and Valleylab.
 
The healthcare company employs over 43,000 people worldwide. As an independent, the company plans to embark on a new direction that focuses exclusively on healthcare and benefits from increased flexibility to invest in innovation and organic growth, the company said.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.